Single Stranded DNA: The Genome's Achilles Heel
Single Stranded DNA: The Genome's Achilles Heel
批准号:
7882988
负责人:
WENYI FENG
金额:
$7.32万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-20 至 2010-08-15
关键词:
Biological AssayCellsChromosome BreakageChromosome Fragile SitesComplexCoupledDNADNA DamageDNA Sequence RearrangementDNA biosynthesisDNA mappingDefectDeoxyribonucleotidesDetectionDevelopmentDiagnosticDiseaseEnsureEukaryotaEventExcisionExposure toGenerationsGenesGeneticGenetic ProcessesGenetic ScreeningGenomeGenomic InstabilityGenomicsGoalsHeelHumanHuman GenomeIncubatedInheritedKaryotype determination procedureLabelLeadLocationMalignant NeoplasmsMapsMethodsMitosisMolecularMutagensMutationOrganismPartner in relationshipPharmaceutical PreparationsPhosphotransferasesPrincipal InvestigatorProcessProductionPulsed-Field Gel ElectrophoresisRecoveryReplication OriginReplication-Associated ProcessReportingResearchResearch PersonnelRoleSaccharomyces cerevisiaeScreening procedureSecureSingle-Stranded DNASiteSouthern BlottingSuppressor GenesSurvivorsTechniquesTestingWorkYeastsbasecomparative genomic hybridizationdensityhuman diseasehydroxyureamembermutantpreventprogramstooltransmission process
中文摘要
描述(由申请人提供):染色体DNA复制是一个高度编排的过程,必须以有序和及时的方式进行,以确保遗传信息的准确传输。我的总体目标是了解染色体DNA复制缺陷引起基因组不稳定和疾病发展的机制。本研究计划围绕探索以下假设:复制检查点缺陷突变体中复制叉停滞和不稳定时的单链DNA(ssDNA)产生是一种有害事件,会阻止基因组的完全合成,导致染色体断裂和基因组不稳定。我的假设基于以下观察:(1)酿酒酵母复制检查点缺陷的rad 53突变细胞含有停滞的复制叉,并在用遗传毒性剂羟基脲(HU)处理后积累大区域的ssDNA;(2)rad 53细胞从短暂暴露于HU中恢复的能力随着暴露持续时间的增加而降低;(3)这些突变细胞在短暂暴露于HU后的生存力不能通过简单地延迟有丝分裂来挽救;(4)rad 53细胞在去除HU后能够合成其大部分基因组DNA,但基因组的某些区域复制不足。
为了验证这一假设,我设计了三个具体目标:
(1)分别通过基于微阵列的密度转移、基于微阵列的基因组ssDNA标记和脉冲场凝胶电泳分析复制动力学、ssDNA产生和染色体完整性,研究在HU中使用rad 53细胞的复制叉不稳定性的后果。
(2)通过进行遗传筛选以分离短暂暴露于HU后rad 53致死性的多拷贝抑制因子,阐明复制叉不稳定性的机制和后果。
(3)将我以前在酵母中开发的基因组ssDNA作图技术应用于(a)绘制人类细胞中的复制起点;(B)鉴定染色体脆性位点并绘制可能导致人类细胞疾病发展的基因组重排的潜在位点。
这项全面的研究计划将使我们能够更广泛地了解真核DNA复制缺陷如何引起基因组不稳定性和人类疾病,如癌症。从长远来看,我希望这项研究将有助于促进人类疾病诊断和治疗工具的发展。
英文摘要
DESCRIPTION (provided by applicant): Chromosomal DNA replication is a highly choreographed process that must take place in an orderly and timely fashion to secure the accurate transmission of genetic information. My general objectives are to understand the mechanisms by which defects in chromosomal DNA replication give rise to genomic instability and disease development. This research plan is centered around exploring the hypothesis that single-stranded DNA (ssDNA) production upon replication fork stalling and destabilization in replication checkpoint-deficient mutants is a detrimental event that prevents complete synthesis of the genome, causes chromosomal breakage and genomic instability. I base this hypothesis on the following observations: (1) Saccharomyces cerevisiae replication checkpoint-deficient rad53 mutant cells contain stalled replication forks and accumulate large regions of ssDNA upon treatment with the genotoxic agent hydroxyurea (HU); (2) the ability of rad53 cells to recover from transient exposure to HU decreases as the duration of exposure increases; (3) viability of these mutant cells after transient exposure to HU cannot be rescued by simply delaying mitosis; (4) rad53 cells, upon removal of HU, are able to synthesize much of their genomic DNA, but certain regions of the genome are under-replicated.
In order to test this hypothesis, I devised three specific aims to:
(1) Investigate the consequence of replication fork instability using rad53 cells in HU through analyzing replication dynamics, ssDNA production, and chromosomal integrity by microarray-based density transfer, microarray-based genomic ssDNA labeling, and pulse field gel electrophoresis, respectively.
(2) Elucidate the mechanism and the consequence of replication fork instability by conducting a genetic screen to isolate multi-copy suppressors of rad53 lethality after transient exposure to HU.
(3) Adapt a genomic ssDNA mapping technique that I previously developed in yeast to (a) map origins of replication in human cells; (b) identify chromosomal fragile sites and map potential sites of genomic rearrangement that may lead to disease development in human cells.
This comprehensive research plan will enable us to gain broader understanding of how defects in eukaryotic DNA replication give rise to genomic instability and human diseases such as cancer. In the long term, I hope that this research will aid in promoting the development of diagnostic and treatment tools for human diseases.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1534/g3.111.000554
发表时间:
2011-10
期刊:
G3 (Bethesda, Md.)
影响因子:
--
作者:
[Feng W, Di Rienzi SC, Raghuraman MK, Brewer BJ]
通讯作者:
Brewer BJ
Understanding the Genome Maintenance Function of the Fragile X Protein (FMRP)
-
批准号:10511129
-
项目类别:
-
资助金额:$24.45万
-
财政年份:2022
-
负责人:WENYI FENG
-
依托单位:
Understanding the Genome Maintenance Function of the Fragile X Protein (FMRP)
-
批准号:10661830
-
项目类别:
-
资助金额:$20.38万
-
财政年份:2022
-
负责人:WENYI FENG
-
依托单位:
Mechanisms of replication stress-induced chromosome fragility
-
批准号:9193425
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2016
-
负责人:WENYI FENG
-
依托单位:
Single Stranded DNA: The Genome's Achilles Heel
-
批准号:8392278
-
项目类别:
-
资助金额:$21.28万
-
财政年份:2007
-
负责人:WENYI FENG
-
依托单位:
Single Stranded DNA: The Genome's Achilles Heel
-
批准号:7477136
-
项目类别:
-
资助金额:$8.85万
-
财政年份:2007
-
负责人:WENYI FENG
-
依托单位:
Single Stranded DNA: The Genome's Achilles Heel
-
批准号:8188793
-
项目类别:
-
资助金额:$22.22万
-
财政年份:2007
-
负责人:WENYI FENG
-
依托单位:
Single Stranded DNA: The Genome's Achilles Heel
-
批准号:7299315
-
项目类别:
-
资助金额:$8.66万
-
财政年份:2007
-
负责人:WENYI FENG
-
依托单位:
Single Stranded DNA: The Genome's Achilles Heel
-
批准号:8204426
-
项目类别:
-
资助金额:$22.33万
-
财政年份:2007
-
负责人:WENYI FENG
-
依托单位:
Investigating of a Novel Checkpoint in S. Cerevisiae
-
批准号:6920712
-
项目类别:
-
资助金额:$4.99万
-
财政年份:2003
-
负责人:WENYI FENG
-
依托单位:
Investigating of a Novel Checkpoint in S. Cerevisiae
-
批准号:6691504
-
项目类别:
-
资助金额:$4.16万
-
财政年份:2003
-
负责人:WENYI FENG
-
依托单位:
Investigating of a Novel Checkpoint in S. Cerevisiae
-
批准号:6778266
-
项目类别:
-
资助金额:$4.73万
-
财政年份:2003
-
负责人:WENYI FENG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
分化肌细胞脱细胞ECM-cells sheet 3D
支架构建及其促进容积性肌组织缺损再
生修复应用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:肖将尉
-
依托单位:
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
-
批准号:82072862
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:徐云升
-
依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
-
批准号:82070825
-
项目类别:面上项目
-
资助金额:53.0万元
-
批准年份:2020
-
负责人:徐西振
-
依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
-
批准号:81903002
-
项目类别:青年科学基金项目
-
资助金额:20.5万元
-
批准年份:2019
-
负责人:王斐斐
-
依托单位:
HA/CD44在乳腺癌转移“先导细胞”(leader cells)侵袭中的作用及机制研究
-
批准号:81402419
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:杨翠霞
-
依托单位:
双模式编码的慢病毒载体转染C6 Glioma Cells的影像学研究
-
批准号:81271563
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2012
-
负责人:陈正光
-
依托单位:
树突状细胞(Dendritic cells,DCs)介导的黏膜免疫对猪轮状病毒(PRV)感染的分子作用机制研究
-
批准号:31272541
-
项目类别:面上项目
-
资助金额:82.0万元
-
批准年份:2012
-
负责人:王春凤
-
依托单位:
MTA2在睾丸支持细胞(Sertoli cells)中的功能和机制研究
-
批准号:31271248
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:李伟
-
依托单位:
无外源性基因iPS cells向肠细胞分化及对肠损伤的修复
-
批准号:81160050
-
项目类别:地区科学基金项目
-
资助金额:49.0万元
-
批准年份:2011
-
负责人:邵立健
-
依托单位: